Class 4 Medicines Defect Information:
Buccolam 10mg Oromucosal solution (Orifarm UK Ltd)
Drug alert number: EL (23)A/18
Date issued: 22 May 2023
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for:
Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272
Batch No
Expiry Date
Pack Size
First Distributed
620903600
08/2024
4 pre-filled oral syringe
11/04/2023
Active Pharmaceutical Ingredient: midazolam hydrochloride
Brief description of the problem
Orifarm UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in one batch of Buccolam 10mg Oromucosal solution has missing information regarding having to break the seal on the inner container before use. All other sections of the PIL are unaffected.
The information in step 1 of the PIL should include text indicating to break the seal at one end:
Step 1 (incorrect PIL)
Step 1 (correct PIL)
Advice for healthcare professionals
Healthcare professionals are advised to inform patients that there is an error in the PIL. The information regarding breaking the seal on the inner container before use as per ‘Step 1 (correct PIL)’ as shown in the images in this notification, should be followed.
The Marketing Authorisation Holder can supply copies of the correct PIL on request, so that any affected packs remaining in the dispensary can be supplemented with the correct information. Future copies of the PIL will reflect the correct information.
View full alert here.
Further Information
For more information, medical or supply enquiries, please contact 01276 698370, or email uk_enquiries@orifarm.com
The post MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) appeared first on PSNC Website.